AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,163,000 | +18.8% | 22,524 | -0.3% | 0.01% | 0.0% |
| Q4 2020 | $979,000 | +24.2% | 22,584 | +0.3% | 0.01% | +16.7% |
| Q3 2020 | $788,000 | -34.7% | 22,524 | -0.1% | 0.01% | -40.0% |
| Q2 2020 | $1,206,000 | +37.0% | 22,544 | -9.1% | 0.01% | +25.0% |
| Q1 2020 | $880,000 | +27.2% | 24,799 | +71.0% | 0.01% | +33.3% |
| Q4 2019 | $692,000 | +73.0% | 14,499 | +17.5% | 0.01% | +50.0% |
| Q3 2019 | $400,000 | -67.8% | 12,339 | -50.4% | 0.00% | -50.0% |
| Q2 2019 | $1,241,000 | -10.1% | 24,889 | +21.7% | 0.01% | -11.1% |
| Q1 2019 | $1,380,000 | +47.6% | 20,459 | +0.9% | 0.01% | +28.6% |
| Q4 2018 | $935,000 | -39.4% | 20,286 | +1.4% | 0.01% | -30.0% |
| Q3 2018 | $1,543,000 | +56.5% | 20,013 | +70.9% | 0.01% | 0.0% |
| Q2 2018 | $986,000 | +143.5% | 11,709 | +136.6% | 0.01% | -9.1% |
| Q1 2018 | $405,000 | – | 4,949 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |